102 related articles for article (PubMed ID: 16091477)
1. Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.
Zatelli MC; Luchin A; Piccin D; Tagliati F; Bottoni A; Vignali C; Bondanelli M; degli Uberti EC
J Clin Endocrinol Metab; 2005 Oct; 90(10):5754-60. PubMed ID: 16091477
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.
Zatelli MC; Luchin A; Tagliati F; Leoni S; Piccin D; Bondanelli M; Rossi R; degli Uberti EC
Endocr Relat Cancer; 2007 Dec; 14(4):1029-38. PubMed ID: 18045954
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
[TBL] [Abstract][Full Text] [Related]
4. [Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
Massart C; Gibassier J; Lucas C; Pourquier P; Robert J
Bull Cancer; 1996 Jan; 83(1):39-45. PubMed ID: 8672855
[TBL] [Abstract][Full Text] [Related]
5. Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells.
Puhlmann U; Ziemann C; Ruedell G; Vorwerk H; Schaefer D; Langebrake C; Schuermann P; Creutzig U; Reinhardt D
J Pharmacol Exp Ther; 2005 Jan; 312(1):346-54. PubMed ID: 15501994
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines.
Buecher B; Bouancheau D; Broquet A; Bezieau S; Denis MG; Bonnet C; Heymann MF; Jarry A; Galmiche JP; Blottière HM
Anticancer Res; 2005; 25(1A):225-33. PubMed ID: 15816542
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
9. Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase.
Quidville V; Segond N; Pidoux E; Cohen R; Jullienne A; Lausson S
Endocrinology; 2004 May; 145(5):2561-71. PubMed ID: 14736730
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
[TBL] [Abstract][Full Text] [Related]
11. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
12. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.
Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q
Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
Massart C; Gibassier J; Raoul M; Pourquier P; Leclech G; Robert J; Lucas C
Anticancer Drugs; 1995 Feb; 6(1):135-46. PubMed ID: 7756676
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
Wu R; Abramson AL; Shikowitz MJ; Dannenberg AJ; Steinberg BM
Clin Cancer Res; 2005 Sep; 11(17):6155-61. PubMed ID: 16144915
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.
Vivaldi A; Ciampi R; Tacito A; Molinaro E; Agate L; Bottici V; Pinchera A; Collecchi P; Elisei R
Mol Cell Endocrinol; 2012 May; 355(1):41-8. PubMed ID: 22305971
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin inhibits cell growth of medullary thyroid carcinoma by reducing cell cycle progression into S phase.
Tomoda C; Moatamed F; Naeim F; Hershman JM; Sugawara M
Exp Biol Med (Maywood); 2008 Nov; 233(11):1433-40. PubMed ID: 18791128
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.
Ye CG; Wu WK; Yeung JH; Li HT; Li ZJ; Wong CC; Ren SX; Zhang L; Fung KP; Cho CH
Cancer Lett; 2011 May; 304(2):90-6. PubMed ID: 21377266
[TBL] [Abstract][Full Text] [Related]
19. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
Bhat UG; Winter MA; Pearce HL; Beck WT
Mol Pharmacol; 1995 Oct; 48(4):682-9. PubMed ID: 7476894
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15.
Saikawa Y; Sugiura T; Toriumi F; Kubota T; Suganuma K; Isshiki S; Otani Y; Kumai K; Kitajima M
Anticancer Res; 2004; 24(5A):2723-8. PubMed ID: 15517878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
